-
ce.effectivehealthcare.ahrq.gov/patient-safety/settings/hospital/vtguide/appc.html
May 01, 2016 - Hemoperitoneum (nontraumatic)
569.3
Hemorrhage of rectum and anus
578.0
Hematemesis
578.1
Blood … in stool
578.9
Hemorrhage of gastrointestinal tract, unspecified
599.70
Hematuria, unspecified … 964.2
Poisoning by anticoagulants
E858.2
Accidental poisoning by agents primarily affecting blood
-
effectivehealthcare-admin.ahrq.gov/products/c-difficile-update/research-protocol
December 01, 2019 - comorbidities, and use of gastric acid suppressant medications. 14 Mortality is associated with age, white blood … assays)
Tests for toxins
Two step strategies
DNA amplification (PCR, LAMP)
Tests of stool … calprotectin)
Comparator groups
Reference Standard: cell cytotoxicity assay and/or toxigenic stool … Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/hai/tools/booklets/laparotomy-patient.pdf
November 01, 2023 - It helps prevent serious problems like blood clots and pneumonia. … If your blood pressure is low, we may have you wait
so you don’t faint or fall. … Find out if you should get anything like:
■ A shower stool, so you can sit down in the shower. … To help prevent blood clots, regularly point and flex your feet and squeeze the muscles in your
legs
-
effectivehealthcare.ahrq.gov/products/c-difficile-update/research-protocol
December 23, 2014 - comorbidities, and use of gastric acid suppressant medications. 14 Mortality is associated with age, white blood … immunochormatography assays)
Tests for toxins
Two step strategies
DNA amplification (PCR, LAMP)
Tests of stool … calprotectin)
Comparator groups
Reference Standard: cell cytotoxicity assay and/or toxigenic stool … Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_research-protocol.pdf
December 23, 2014 - comorbidities, and use of gastric acid suppressant medications.14 Mortality is associated with
age, white blood … immunochormatography assays)
• Tests for toxins
• Two step strategies
• DNA amplification (PCR, LAMP)
Tests of stool … fecal
calprotectin)
Comparator groups Reference Standard: cell cytotoxicity assay
and/or toxigenic stool … Impact of changes in clostridium difficile
testing practices on stool rejection policies
and C. difficile
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/c-difficile-update_research-protocol.pdf
December 23, 2014 - comorbidities, and use of gastric acid suppressant medications.14 Mortality is associated with
age, white blood … immunochormatography assays)
• Tests for toxins
• Two step strategies
• DNA amplification (PCR, LAMP)
Tests of stool … fecal
calprotectin)
Comparator groups Reference Standard: cell cytotoxicity assay
and/or toxigenic stool … Impact of changes in clostridium difficile
testing practices on stool rejection policies
and C. difficile
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0083-fullreport.pdf
March 01, 2016 - Mediolateral
episiotomy is associated with difficulty of repair, greater blood loss, and possibly, increased … • The likelihood of leaking stool or gas.
• Pain with intercourse. … The prospective studies examined did not identify improvements in continence for urine
or stool or in … episiotomy for the
purpose of preventing pelvic floor defects, urinary incontinence, or incontinence of stool
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0083episiotomy.pdf
March 01, 2016 - Mediolateral
episiotomy is associated with difficulty of repair, greater blood loss, and possibly, increased … • The likelihood of leaking stool or gas.
• Pain with intercourse. … The prospective studies examined did not identify improvements in continence for urine
or stool or in … episiotomy for the
purpose of preventing pelvic floor defects, urinary incontinence, or incontinence of stool
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/frontline-cases-studies.pdf
May 01, 2015 - To properly quantify blood loss, the team made a number of changes to the equipment and
information … Previously, blood loss was estimated
visually, which was highly imprecise and often inaccurate. … Weighing the absorbent pads allows
for a consistent and accurate way to quantify blood loss. … The change also involved quantification of total blood loss, which included blood loss
before and after … loss, blood pressure, and administration of
uterotonics
• Developed and included a “problem list”
-
www.cpsi.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/frontline-cases-studies.pdf
May 01, 2015 - To properly quantify blood loss, the team made a number of changes to the equipment and
information … Previously, blood loss was estimated
visually, which was highly imprecise and often inaccurate. … Weighing the absorbent pads allows
for a consistent and accurate way to quantify blood loss. … The change also involved quantification of total blood loss, which included blood loss
before and after … loss, blood pressure, and administration of
uterotonics
• Developed and included a “problem list”
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/frontline-cases-studies.pdf
May 01, 2015 - To properly quantify blood loss, the team made a number of changes to the equipment and
information … Previously, blood loss was estimated
visually, which was highly imprecise and often inaccurate. … Weighing the absorbent pads allows
for a consistent and accurate way to quantify blood loss. … The change also involved quantification of total blood loss, which included blood loss
before and after … loss, blood pressure, and administration of
uterotonics
• Developed and included a “problem list”
-
healthcare411.ahrq.gov/hai/pfp/haccost2017.html
November 01, 2017 - Central Line-Associated Blood Stream Infections.
Clostridium difficile Infections.
Falls. … Drug Events (ADE)
Catheter-Associated Urinary Tract Infections (CAUTI)
Central Line-Associated Blood … Central Line-Associated Bloodstream Infections (CLABSI)
Infection of the blood stream that occurs subsequent … confirmation (i.e., positive test results for CDI toxin A and/or B or toxin producing CDI organism found in stool
-
cahps.ahrq.gov/hai/pfp/haccost2017.html
November 01, 2017 - Central Line-Associated Blood Stream Infections.
Clostridium difficile Infections.
Falls. … Drug Events (ADE)
Catheter-Associated Urinary Tract Infections (CAUTI)
Central Line-Associated Blood … Central Line-Associated Bloodstream Infections (CLABSI)
Infection of the blood stream that occurs subsequent … confirmation (i.e., positive test results for CDI toxin A and/or B or toxin producing CDI organism found in stool
-
monahrq.ahrq.gov/hai/pfp/haccost2017.html
November 01, 2017 - Central Line-Associated Blood Stream Infections.
Clostridium difficile Infections.
Falls. … Drug Events (ADE)
Catheter-Associated Urinary Tract Infections (CAUTI)
Central Line-Associated Blood … Central Line-Associated Bloodstream Infections (CLABSI)
Infection of the blood stream that occurs subsequent … confirmation (i.e., positive test results for CDI toxin A and/or B or toxin producing CDI organism found in stool
-
preventiveservices.ahrq.gov/hai/pfp/haccost2017.html
November 01, 2017 - Central Line-Associated Blood Stream Infections.
Clostridium difficile Infections.
Falls. … Drug Events (ADE)
Catheter-Associated Urinary Tract Infections (CAUTI)
Central Line-Associated Blood … Central Line-Associated Bloodstream Infections (CLABSI)
Infection of the blood stream that occurs subsequent … confirmation (i.e., positive test results for CDI toxin A and/or B or toxin producing CDI organism found in stool
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule-future_research.pdf
May 01, 2013 - Although colonic and gastric dysmotility are not as common as high blood
pressure or diabetes, the burden … decrease in a person’s normal frequency of
stools that is accompanied by straining, difficulty passing stool … gastric emptying study performance to be optimal and
reproducible, the patients should have controlled blood … protocol,
prespecify which
protocol and timing
of ingestion
Prespecify x-ray timing
to document stool … Although colonic and gastric dysmotility are not as common as high blood pressure or diabetes,
the burden
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule-future_research.pdf
May 01, 2013 - Although colonic and gastric dysmotility are not as common as high blood
pressure or diabetes, the burden … decrease in a person’s normal frequency of
stools that is accompanied by straining, difficulty passing stool … gastric emptying study performance to be optimal and
reproducible, the patients should have controlled blood … protocol,
prespecify which
protocol and timing
of ingestion
Prespecify x-ray timing
to document stool … Although colonic and gastric dysmotility are not as common as high blood pressure or diabetes,
the burden
-
effectivehealthcare-admin.ahrq.gov/products/cancer-quality-indicator-testing/research
January 01, 2020 - and communication are very different from those assessing discrete, concrete events like fecal occult blood … uncomplicated all of the following should be assessed: · history of onset and duration,· number of stools and stool
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/ontime/pruprev/ereports.html
December 01, 2014 - Examples of an acute change in health status are elevated temperature with blood cultures obtained or … Temperature
99.2
Pulse
82
88
90
100
Respirations
20
20
20
20
Blood … 0
25
0
0
Bowel
Habits
Continent
Continent
Incontinent
Incontinent
Loose stool
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
April 01, 2010 - communication are very
different from those assessing discrete, concrete events like fecal occult blood … uncomplicated all of the following
should be assessed: · history of onset and duration,· number of stools and stool